首页> 外文期刊>World Journal of Gastroenterology >Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C
【24h】

Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C

机译:α2b干扰素对慢性丙型肝炎患者PBMC诱导mIL-2R的影响和HCV的治疗

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the level of membrane interleukin-2 receptor (mIL-2R) on surface of peripheral blood mononuclear cells (PBMC) and the therapeutic efficacy of alpha 2b interferon on the treatment of HCV-RNA in PBMC of patients with chronic hepatitis C and to compare the negative rates of HCV-RNA in PBMC, HCV-RNA and anti-HCV in serum. METHODS: Before and after treatment of alpha 2b interferon, the level of mIL-2R of patients with chronic hepatitis C was detected by biotin-streptavidin (BSA). The therapeutic group (26 cases) was treated with alpha 2b interferon (3 MU/d) and control therapeutic group (22 cases) was treated with routine drugs (VitC, aspartic acid). The total course of treatment with alpha 2b interferon and routine drug was six months and per course of the treatment was three months. The levels of HCV-RNA in PBMC, HCV-RNA and anti-HCV in serum were detected before and after a course of the treatment. RESULTS: Before and after treatment of alpha 2b interferon and routine drugs, the levels of mIL-2R in silence stage were (3.44+-0.77) % and (2.95+-0.72) %, the levels of mIL-2R in inducement stage were (33.62+-3.95) % and (30.04+-3.73) %. There was a significant difference between two groups (P<0.01-P<0.05). After treatment of alpha 2b interferon with 3 MU/d for two courses of the treatment, the total negative rates of HCV-RNA in the PBMC and HCV-RNA, anti-HCV in serum were 42.31 % (11/26), 57.69 % (15/26), 65.38 %(17/26) respectively. After the treatment of routine drug, the negative rates of HCV-RNA in PBMC and HCV-RNA, anti-HCV in serum were 13.64 % (3/22), 22.73 % (5/22), 27.27 % (6/22) respectively. There was high significant difference in the group treated with alpha 2b interferon and the group treated with routine drugs CONCLUSION: The mIL-2R can be induced by alpha 2b interferon during the treatment. The alpha 2b interferon has a definite effect on the treatment of HCV-RNA in PBMC. The curative effect of alpha 2b interferon is better than that of the routine drugs.
机译:目的:研究外周血单个核细胞(PBMC)表面膜白介素2受体(mIL-2R)的水平以及α2b干扰素对慢性丙型肝炎患者PBMC中HCV-RNA的治疗作用并比较PBMC中HCV-RNA的阴性率,血清中HCV-RNA和抗HCV的阴性率。方法:在α2b干扰素治疗前后,通过生物素-链霉亲和素(BSA)检测慢性丙型肝炎患者的mIL-2R水平。治疗组(26例)接受α2b干扰素治疗(3 MU / d),对照组治疗组(22例)接受常规药物(VitC,天冬氨酸)治疗。使用α2b干扰素和常规药物的总疗程为6个月,每个疗程为3个月。在疗程之前和之后,检测PBMC中的HCV-RNA水平,血清中的HCV-RNA和抗HCV水平。结果:α2b干扰素和常规药物治疗前后,沉默期的mIL-2R水平分别为(3.44 + -0.77)%和(2.95 + -0.72)%,诱导期的mIL-2R水平为(33.62 + -3.95)%和(30.04 + -3.73)%。两组之间有显着差异(P <0.01-P <0.05)。在两个疗程中以3 MU / d的剂量治疗α2b干扰素后,PBMC中的HCV-RNA和血清中的HCV-RNA和抗HCV的总阴性率为42.31%(11/26),57.69% (15/26),65.38%(17/26)。常规药物治疗后,PBMC中HCV-RNA和血清中HCV-RNA,抗HCV的阴性率分别为13.64%(3/22),22.73%(5/22),27.27%(6/22)分别。结论:α2b干扰素治疗组与常规药物治疗组差异有统计学意义。结论:α2b干扰素可诱导mIL-2R的产生。 α2b干扰素对PBMC中HCV-RNA的治疗具有明确的作用。 α2b干扰素的疗效优于常规药物。

著录项

  • 来源
    《World Journal of Gastroenterology》 |2003年第4期|p.751-754|共4页
  • 作者单位

    Department of Aetiology and Immunology, Anhui University of Science and Technology, Huainan 232001, Anhui Province, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 消化系及腹部疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号